Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis

Status unconfirmed

Conditions studied: Osteoarthritis

In brief

The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on joint pain and functionality in people with Osteoarthritis (OA). SVF contains components with "regenerative" properties, including stem cells that have shown promise for ameliorating specific disease conditions. This study is designed to evaluate joint pain and functionality changes in individuals with OA for up to 12 months following SVF treatment.

Key facts

Study ID

NCT02241408

Run by

StemGenex

People needed

100

Starts

2014-09-01

Expected to finish

2019-09-01

Last updated by the study team

2018-08-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fluent in English
• Over the age of 18
• Diagnosed with OA of the knee and/or hip
• Scheduled for intravenous and intra-articular administrations of autologous SVF
• Capable of understanding and willing to sign informed consent
• Willing and able to complete brief phone interviews
• Willing and able to complete online surveys

You may not qualify if…

• Co-morbidity with an autoimmune disorder
• Pregnant, may become pregnant, or breastfeeding
• Subjects for which baseline data is not available

Where it is running

• StemGenex — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.